Linifanib (ABT-869)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Linifanib (ABT-869), covering 2017-11-21 to 2017-11-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC) [Phase 1]